1FDA. FDA Requires Boxed Warning and Risk Mitigation Strategy for Metoclopramide-Containing Drugs. [ EB/OL]. 2009-2- 26. http ://www. fda. gov/bbs/topics/NEWS/2009/NEW01963, html. 被引量：1
2Lavy S, Melamed E, Penckas S. Tardive dyskinesia associated with metoclopramide [ J ]. Br Med J, 1978, 1:77-78. 被引量：1
3Wiholm BE, Mortimer O, Boethius G, et al. Tardive deskinesia, associated with metoclopramide[ J]. Br Med J, 1984, 288: 545 -547. 被引量：1
4Breitbart W, Mortimer O, Boethius G. Tardive dyskinesia associated with high dose intravenous metoclopramide [ J ]. N Engl J Med, 1986, 315: 518. 被引量：1
